Evidence map›Paper›PMID 26206086›Full record

ArticleCell death and differentiation2016

The SR/ER-mitochondria calcium crosstalk is regulated by GSK3β during reperfusion injury.

L Gomez, P-A Thiebaut, M Paillard, S Ducreux, M Abrial, C Crola Da Silva, A Durand, M R Alam, F Van Coppenolle, S-S Sheu and 1 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

L GomezINSERM UMR-1060, Laboratoire CarMeN, Université Lyon 1, Faculté de medicine, Rockefeller et Charles Merieux Lyon-Sud, Lyon 69003, France.
P-A ThiebautINSERM UMR-1060, Laboratoire CarMeN, Université Lyon 1, Faculté de medicine, Rockefeller et Charles Merieux Lyon-Sud, Lyon 69003, France.
M PaillardINSERM UMR-1060, Laboratoire CarMeN, Université Lyon 1, Faculté de medicine, Rockefeller et Charles Merieux Lyon-Sud, Lyon 69003, France.
S DucreuxINSERM UMR-1060, Laboratoire CarMeN, Université Lyon 1, Faculté de medicine, Rockefeller et Charles Merieux Lyon-Sud, Lyon 69003, France.
M AbrialINSERM UMR-1060, Laboratoire CarMeN, Université Lyon 1, Faculté de medicine, Rockefeller et Charles Merieux Lyon-Sud, Lyon 69003, France.
C Crola Da SilvaINSERM UMR-1060, Laboratoire CarMeN, Université Lyon 1, Faculté de medicine, Rockefeller et Charles Merieux Lyon-Sud, Lyon 69003, France.
A DurandINSERM UMR-1060, Laboratoire CarMeN, Université Lyon 1, Faculté de medicine, Rockefeller et Charles Merieux Lyon-Sud, Lyon 69003, France.
M R AlamINSERM UMR-1060, Laboratoire CarMeN, Université Lyon 1, Faculté de medicine, Rockefeller et Charles Merieux Lyon-Sud, Lyon 69003, France.
F Van CoppenolleINSERM UMR-1060, Laboratoire CarMeN, Université Lyon 1, Faculté de medicine, Rockefeller et Charles Merieux Lyon-Sud, Lyon 69003, France.
S-S SheuHospices Civils de Lyon, Hôpital Louis Pradel, Service d'Explorations Fonctionnelles, Cardiovasculaires and CIC de Lyon, Lyon 69394, France.
M OvizeINSERM UMR-1060, Laboratoire CarMeN, Université Lyon 1, Faculté de medicine, Rockefeller et Charles Merieux Lyon-Sud, Lyon 69003, France.
Laboratoire CarMeN · FRUniversité Claude Bernard Lyon 1 · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycogen synthase kinase-3β (GSK3β) is a multifunctional kinase whose inhibition is known to limit myocardial ischemia-reperfusion injury. However, the mechanism mediating this beneficial effect still remains unclear. Mitochondria and sarco/endoplasmic reticulum (SR/ER) are key players in cell death signaling. Their involvement in myocardial ischemia-reperfusion injury has gained recognition recently, but the underlying mechanisms are not yet well understood. We questioned here whether GSK3β might have a role in the Ca(2+) transfer from SR/ER to mitochondria at reperfusion. We showed that a fraction of GSK3β protein is localized to the SR/ER and mitochondria-associated ER membranes (MAMs) in the heart, and that GSK3β specifically interacted with the inositol 1,4,5-trisphosphate receptors (IP3Rs) Ca(2+) channeling complex in MAMs. We demonstrated that both pharmacological and genetic inhibition of GSK3β decreased protein interaction of IP3R with the Ca(2+) channeling complex, impaired SR/ER Ca(2+) release and reduced the histamine-stimulated Ca(2+) exchange between SR/ER and mitochondria in cardiomyocytes. During hypoxia reoxygenation, cell death is associated with an increase of GSK3β activity and IP3R phosphorylation, which leads to enhanced transfer of Ca(2+) from SR/ER to mitochondria. Inhibition of GSK3β at reperfusion reduced both IP3R phosphorylation and SR/ER Ca(2+) release, which consequently diminished both cytosolic and mitochondrial Ca(2+) concentrations, as well as sensitivity to apoptosis. We conclude that inhibition of GSK3β at reperfusion diminishes Ca(2+) leak from IP3R at MAMs in the heart, which limits both cytosolic and mitochondrial Ca(2+) overload and subsequent cell death.

Indexed as

Calcium SignalingAnimalsCalciumCell LineGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaInositol 1,4,5-Trisphosphate ReceptorsMaleMice, Inbred C57BLMitochondria, HeartMyocardial Reperfusion InjuryMyocardiumMyocytes, CardiacPhosphorylationProtein Processing, Post-TranslationalSarcoplasmic ReticulumCalciumGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGsk3b protein, mouseInositol 1,4,5-Trisphosphate Receptors

Identifiers

PMID26206086
PMCPMC4716295
OpenAlexW1554924288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.